NIH renews $13M contract with Penn’s gene therapy program

The National Institutes of Health has once again renewed a five-year contract with the University of Pennsylvania’s gene therapy program, which will receive $13 million to support the advancement of gene-therapy research to the clinic. The contract was awarded by National Heart, Lung and Blood Institute to what operates as the Gene Therapy Program Preclinical…

Read More